SEC Form 4 research
| Issuer | RedHill Biopharma Ltd. |
|---|---|
| Tickers | RDHL |
| Reporting owners | 10 |
| Officers and directors | 1 |
| Last public filing | 2026-10-06 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-10-06 | 2026-10-01 | Raday Gilead | S | 14,310,000 | $0 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.